Peter J. Roy

The forkhead transcription factor UNC-130 is required for the graded spatial expression of the UNC-129 TGF-beta guidance factor in C. elegans.

Muscle arm development in Caenorhabditis elegans.

Network news: functional modules revealed during early embryogenesis in C. elegans.

FGF negatively regulates muscle membrane extension in Caenorhabditis elegans.

A small-molecule screen in C. elegans yields a new calcium channel antagonist.

High-throughput screening of small molecules for bioactivity and target identification in Caenorhabditis elegans.

Cell-specific microarray profiling experiments reveal a comprehensive picture of gene expression in the C. elegans nervous system.

A global analysis of genetic interactions in Caenorhabditis elegans.

Identification of small molecule inhibitors of Pseudomonas aeruginosa exoenzyme S using a yeast phenotypic screen.

A predictive model for drug bioaccumulation and bioactivity in Caenorhabditis elegans.

MADD-2, a homolog of the Opitz syndrome protein MID1, regulates guidance to the midline through UNC-40 in Caenorhabditis elegans.

MADD-4 is a secreted cue required for midline-oriented guidance in Caenorhabditis elegans.

Compound prioritization methods increase rates of chemical probe discovery in model organisms.

Dafadine inhibits DAF-9 to promote dauer formation and longevity of Caenorhabditis elegans.

Orthosteric and allosteric drug binding sites in the Caenorhabditis elegans mgl-2 metabotropic glutamate receptor.

EVA-1 functions as an UNC-40 Co-receptor to enhance attraction to the MADD-4 guidance cue in Caenorhabditis elegans.

Caenorhabditis elegans is a useful model for anthelmintic discovery.

The MADD-3 LAMMER Kinase Interacts with a p38 MAP Kinase Pathway to Regulate the Display of the EVA-1 Guidance Receptor in Caenorhabditis elegans.

The novel nematicide wact-86 interacts with aldicarb to kill nematodes.

The marginal cells of the Caenorhabditis elegans pharynx scavenge cholesterol and other hydrophobic small molecules.

Author Correction: Caenorhabditis elegans is a useful model for anthelmintic discovery.

A survey of the kinome pharmacopeia reveals multiple scaffolds and targets for the development of novel anthelmintics.